OCS

7.0605.11%
RS

Riad Sherif

CEO & Director

Dr. Riad Sherif, MD, MBA, is Director of Ocular Therapeutix, Inc. from November 6, 2026. Dr. Sherif has been the Chief Executive Officer and Director of Oculis Holding AG (formerly known as Oculis SA) since December 2017. He is Chief Executive Officer and Director of Oculis ehf. He serves as an Independent Director at Revenio Group Oyj since April 8, 2022. Dr. Sherif served as Region President of Europe, Middle East and Africa at Alcon, Inc. Dr. Sherif joined Alcon from Novartis Pharmaceuticals, where he served as President of Novartis Pharmaceuticals, Canada, Inc. He has extensive experience in the pharmaceutical industry. Dr. Sherif joined Novartis in 2002, as a Global Sales Manager and later became Head of Global Sales for the Transplant and Immunology Business Unit at Novartis Headquarters in Basel, Switzerland. In 2004, Dr. Sherif moved to Argentina to take on the responsibility of Head of Transplant and Infectious Disease for Latin America and was promoted in 2007 to the position of Head of the Novartis Vaccines and Diagnostics Division for Latin America, based in Buenos Aires, Argentina. Prior to Novartis, Dr. Sherif worked for several pharmaceutical companies, holding positions of increasing importance, mainly in marketing and general management with international scope. Dr. Sherif earned his medical degree from ?cole de M?decine d?Alger in Algeria. Dr. Sherif previously served as the Vice Chairman for the Innovative Medicine Canada Association, as the Chairman of In-Vivo Montreal and as the Chairman of the Board Ophthalmic Surgery and Vision Care of Eucomed. He also has an MBA from IMD Lausanne, Switzerland and a Specialized Master in Medical Management degree from ?cole Sup?rieure de Commerce de Paris, France. Dr. Sherif holds an M.D. from the Medical School of Algiers.

公司職務